|
National Academy of Clinical Biochemistry
Citations 11-20 of 21 total displayed.
|
Past content
(since Jan 1997):
|
- NACB Symposium
Standards of laboratory practice: cardiac drug monitoring
- Roland Valdes, Jr., Saeed A. Jortani, and Mihai Gheorghiade
Clin. Chem. 1998; 44: 1096-1109.
[Abstract]
[Full text]
[PDF]
- NACB Symposium
Standards of laboratory practice: analgesic drug monitoring
- Suzanne White and Steven H. Y. Wong
Clin. Chem. 1998; 44: 1110-1123.
[Abstract]
[Full text]
[PDF]
- NACB Symposium
Standards of laboratory practice: theophylline and caffeine monitoring
- Amadeo J. Pesce, Mitchell Rashkin, and Uma Kotagal
Clin. Chem. 1998; 44: 1124-1128.
[Abstract]
[Full text]
[PDF]
- NACB Symposium
Laboratory guidelines for monitoring of antimicrobial drugs
- Catherine A. Hammett-Stabler and Thomas Johns
Clin. Chem. 1998; 44: 1129-1140.
[Abstract]
[Full text]
[PDF]
- NACB
Introduction and Summary: 1996 NACB Standard of Laboratory Practice
- Lawrence A. Kaplan
Clin. Chem. 1997; 43: 202-204.
[Extract]
[Full text]
[PDF]
- NACB
Assessing fluid and electrolyte status in the newborn
- John M. Lorenz
Clin. Chem. 1997; 43: 205-210.
[Abstract]
[Full text]
[PDF]
- NACB
Standards of laboratory practice: evaluation of fetal lung maturity
- Edward R. Ashwood
Clin. Chem. 1997; 43: 211-214.
[Abstract]
[Full text]
[PDF]
- NACB
Therapeutic drug monitoring principles in the neonate
- Gideon Koren
Clin. Chem. 1997; 43: 222-227.
[Abstract]
[Full text]
[PDF]
- NACB
Assessing liver function and hyperbilirubinemia in the newborn
- Philip Rosenthal
Clin. Chem. 1997; 43: 228-234.
[Abstract]
[Full text]
[PDF]
- NACB
Detection of intrauterine illicit drug exposure by newborn drug testing
- Tai C. Kwong and Rita M. Ryan
Clin. Chem. 1997; 43: 235-242.
[Abstract]
[Full text]
[PDF]
|
|
